🇺🇸 FDA

Intelligence Platform

Patents

Browse 5 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12240846

5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases

Enliven Inc. · Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11807638

5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases

Enliven Inc. · Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11807649

Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2

EnLiven Therapeutics, Inc. · Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11767321

5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases

Enliven Inc. · Granted Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10888597

Composition for treating brain stroke

ENLIVEN BIOTECHNOLOGY CO, LTD. · Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted